1. 1891O_PRMutational landscape of metastatic cancers discovered from prospective clinical sequencing at community practice cancer program. (23rd October 2018) Authors: Alvarez, R H; Moran, A; Meiri, E; Loaiza-Bonilla, A; Parikh, A R; Crilley, P; Elvin, J; Reddy, P; Miller, V A; Zook, S; Ali, S M; Markman, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 311PEarly results from an open-label phase 1b/II study of eribulin mesylate (EM) + pegvorhyaluronidase alfa (PEGHP20) combination for the treatment of patients with HER2-negative, high-hyaluronan (HA) metastatic breast cancer (MBC). (23rd October 2018) Authors: Shum, M; Assikis, V J; Savulsky, C; Zhu, W; Iyer, P; Xing, D; Berman, C; Lokker, N A; Alvarez, R H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 448TiPMEDIOLA: A phase I/II trial of olaparib (PARP inhibitor) in combination with durvalumab (anti-PD-L1 antibody) in pts with advanced solid tumours – new ovarian cancer cohorts. (23rd October 2018) Authors: Penson, R T; Drew, Y; de Jonge, M J A; Hong, S-H; Park, Y H; Wolfer, A; Brown, J; Ferguson, M; Gore, M E; Alvarez, R H; Kaufman, B; Gresty, C; Angell, H K; Meyer, K; Lanasa, M; Herbolsheimer, P; Domchek, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 78PDetection of targetable kinase fusions in 7260 patients in an integrated cancer system. (23rd October 2018) Authors: Parikh, A; Ali, S M; Moran, A; Crilley, P; Schrock, A B; Tan, A; Reddy, P; Miller, V A; Ross, J S; Zook, S; Alvarez, R H; Markman, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗